| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/0891988706298627 © 2007 SAGE Publications Polymorphisms and Vascular Cognitive Impairment After Ischemic StrokeDepartment of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong, lwbaum{at}cuhk.edu.hk
Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Shatin, Hong Kong
Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Shatin, Hong Kong
Professional Programme of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong
Professional Programme of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong
Professional Programme of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong
Department of Rehabilitation, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P.R. China
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong
Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Shatin, Hong Kong
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong Environmental and genetic factors may both affect the risk of vascular cognitive impairment developing after a stroke. To identify factors affecting this risk, the cognitive status of 121 patients was examined 3 months after an ischemic stroke. In all patients and in 270 control subjects, 7 polymorphisms reported to affect risk of vascular ischemic disease were genotyped. In 51 patients (42.1%), vascular cognitive impairment resulted, defined by a Mini-Mental State Examination score of less than 24. These patients were older and more likely to be women. Alleles of none of the polymorphisms differed between patients with or without vascular cognitive impairment, except for glutamate-cysteine ligase modifier (GCLM) (odds ratio = 2.8, P = .006). When all stroke patients were considered, the GCLM genotype did not affect Mini-Mental State Examination scores. Testing the GCLM genotype in an independent group of stroke patients may determine whether this association with vascular cognitive impairment is genuine. ( J Geriatr Psychiatry Neurol 2007;20:93-99)
Key Words: apolipoprotein E lipoprotein lipase glutamate-cysteine ligase modifier ischemic stroke dementia
|